By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AdvanDx, Inc. 

400 TradeCenter
Suite 6990
Woburn  Massachusetts  01801  U.S.A.
Phone: 781-376-0009 Fax: 781-376-0111


SEARCH JOBS


Industry
Diagnostics






Company News
Data From Thirteen Studies Highlighting AdvanDx, Inc.'s Infectious Disease Assays To Be Presented At The 114th General Meeting Of The American Society of Microbiology (ASM) 5/19/2014 6:21:09 AM
AdvanDx, Inc. Raises $12 Million To Accelerate The Expansion Of The Company's Molecular Diagnostic Product Offerings 4/8/2014 8:17:32 AM
AdvanDx, Inc. Announces FDA 510(K) Submission For Meca Xpressfish™ -- A New Method For Rapid Detection Of Methicillin-Resistant Staphylococcus Aureus (MRSA) From Positive Blood Cultures 3/18/2014 10:50:47 AM
AdvanDx, Inc. Adds Gram-Negative BC Assay to U.S. and E.U. Commercial Launch of QuickFISH(TM) - a 20 Min. Pathogen ID Platform for the Identification & Treatment of Sepsis 8/14/2013 9:24:39 AM
AdvanDx, Inc. Elects Former Roche Molecular Systems, Inc. (RHHBF.PK) CEO, Heiner Dreismann, Ph.D., to Its Board of Directors 3/27/2013 10:58:50 AM
AdvanDx, Inc. Adds Enterococcal Bacteremia Assay to U.S. and E.U. Commercial Launch of QuickFISH™ (20 Min. Pathogen ID) Platform 1/10/2013 9:12:10 AM
AdvanDx, Inc. Announces U.S. and E.U. Commercial Launch of QuickFISH™ (20 Min. Pathogen ID), the First Molecular Test to Enable Reporting of Pathogen Identification at the Time of Gram Stain Results From Positive Blood Cultures 9/10/2012 9:29:48 AM
AdvanDx, Inc. to Unveil QuickFISHâ„¢ (20 Min. Pathogen ID) at ECCMID 2012 3/15/2012 10:44:46 AM
AdvanDx, Inc. Release: New Study Shows PNA FISH(R) Test Reporting Dramatically Decreased Mortality and Hospital Costs for Patients with Bloodstream Infections 10/13/2011 10:55:05 AM
AdvanDx, Inc. Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R) 1/18/2011 6:34:29 AM
12345
//-->